Chikungunya
📧 Sign up to get email alerts when something new happens for Chikungunya.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2026-03-13Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 March 2026
PRAC warned of a known risk of aseptic meningitis with the chikungunya vaccine Ixchiq, prompting safety communications.
-
EMA safety_alert · 2025-07-25Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
EMA says the temporary restriction on vaccinating people aged 65 and older with Ixchiq will be lifted. Vaccination should still be considere…
-
EMA safety_alert · 2025-07-11Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
The European Medicines Agency has announced that the temporary restriction on vaccinating people aged 65 years and older with Ixchiq will be…
-
EMA safety_alert · 2025-05-07EMA starts review of Ixchiq (live attenuated chikungunya vaccine)
EMA has started a regulatory review of Ixchiq, a live attenuated chikungunya vaccine, and it should not be used in people aged 65 years and …